Feeling trapped in a cycle of exhaustion, Melissa Red Hoffman, a 50-year-old surgeon from Asheville, N.C., battled with long COVID for over two years. The relentless fatigue weighed heavily on her, affecting her daily life and work. However, a ray of hope emerged when she discovered Remission Biome, a groundbreaking research initiative launched in early 2023 by individuals with ME/CFS. This project aimed to explore the potential link between gut bacteria and overall health improvement in patients with chronic illnesses like long COVID and ME/CFS. Following promising results from an initial trial, the project expanded to include 50 participants, including Hoffman, who eagerly joined the “Renegade 50” group.
Remission Biome’s innovative protocol involves a series of steps that participants undertake under medical supervision. From collecting samples to analyzing data and implementing a regimen of supplements and antibiotics, the project focuses on altering the gut microbiome to alleviate symptoms. Throughout the process, participants monitor their progress and stay informed about the scientific basis behind each intervention, empowering them to take control of their health journey.
2024-03-28 11:00:00
Originally published on www.sciencenews.org
